CIMT plus non-invasive cerebellar tDCS to help upper limb recovery after stroke in women
Official title: Effects of a Neurorehabilitation Program Based on Constraint-Induced Movement Therapy (CIMT) and Non-invasive Neuromodulation Through Cerebellar Transcranial Direct Current Stimulation (C-tDCS) on the Recovery of Paretic Upper Limb Function, Quality of Life, and Therapeutic Alliance in Women From the Araucanía Region Who Suffered a Stroke.
Run by Universidad de La Frontera · NCT07619703 · Data updated 2026-11-12
This study tests whether a rehabilitation program combining Constraint-Induced Movement Therapy and cerebellar tDCS can improve arm function and quality of life for women in the Araucanía region after a stroke.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 85 Years |
| Sex | Women only |
| Enrollment | 24 (estimated) |
| Sponsor | Universidad de La Frontera Academic / other |
| Locations | 1 site (Temuco, Araucania) |
| Status | Recruiting |
| Started | March 1, 2026 |
| Main results expected | September 1, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | June 3, 2026 |
| Trial ID | NCT07619703 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 30–80 who have had a stroke at least one month prior, with some trunk control and adequate cognitive function.
✕Probably not a fit
Individuals with significant shoulder pain, high spasticity, sensory deficits, aphasia, certain implants, recent psychiatric disorders, or pregnancy may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-blind randomized trial will compare a CIMT-based rehab program with and without cerebellar transcranial direct current stimulation in women who have had a stroke. Participants will undergo 10 sessions over two weeks and be assessed at five time points for upper-limb function, quality of life, and therapeutic alliance. Outcomes include motor capacity tests, daily-use measures, and patient-reported quality of life. The trial aims to determine if adding C-tDCS to CIMT provides additional benefit beyond CIMT alone. Data collection will occur at pre-treatment, mid-treatment, post-treatment, and during two follow-up visits.
Why it matters
Potential benefit: If successful, participants may experience greater improvements in arm function and overall quality of life after stroke.
How similar studies have gone: Prior studies in neurorehabilitation suggest CIMT and non-invasive neuromodulation can improve motor outcomes, but the specific combination with cerebellar tDCS in this population is novel/less established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged between 30 and 80 years. * Who present hemorrhagic or ischemic stroke confirmed by CT with evolution greater than 1 month, corroborated by discharge epicrisis supporting the diagnosis of the patient. * Who presents trunk control in sitting. * Score greater than 14 points on the Minimental Examination scale. * Function of the upper extremity, referring to taking and releasing a small ball with the affected hand and signing or accepting the consent written informed. Exclusion Criteria: * Shoulder pain greater than 4 according to the VAS scale and spasticity greater than 2 according to the Modified Ashworth Scale. * Sensory compromise (visual-auditory). * Presence of severe aphasia. * Cochlear implants, aneurysm clips, brain electrodes and cardiac pacemaker. * Epilepsy or psychiatric disorders (diagnosed in the last 3 months). * Pregnancy, use of psychotropic medications.
Where it's running
-
Universidad de La Frontera, Temuco, Chile.
Temuco, Araucania, Chile Recruiting
Study contacts
- Study coordinator: Arlette Doussoulin, PhD
- Email: arlette.doussoulin@ufrontera.cl
- Phone: +56997445912
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.